Literature DB >> 33271061

Guide RNA Categorization Enables Target Site Choice in Tn7-CRISPR-Cas Transposons.

Michael T Petassi1, Shan-Chi Hsieh1, Joseph E Peters2.   

Abstract

CRISPR-Cas defense systems have been coopted multiple times in nature for guide RNA-directed transposition by Tn7-like elements. Prototypic Tn7 uses dedicated proteins for two targeting pathways: one targeting a neutral and conserved attachment site in the chromosome and a second directing transposition into mobile plasmids facilitating cell-to-cell transfer. We show that Tn7-CRISPR-Cas elements evolved a system of guide RNA categorization to accomplish the same two-pathway lifestyle. Multiple mechanisms allow functionally distinct guide RNAs for transposition: a conventional system capable of acquiring guide RNAs to new plasmid and phage targets and a second providing long-term memory for access to chromosomal sites upon entry into a new host. Guide RNAs are privatized to be recognized only by the transposon-adapted system via sequence specialization, mismatch tolerance, and selective regulation to avoid toxic self-targeting by endogenous CRISPR-Cas defense systems. This information reveals promising avenues to engineer guide RNAs for enhanced CRISPR-Cas functionality for genome modification.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR regulation; RNA-directed transposition; guide RNA categorization; self-targeting spacers

Mesh:

Substances:

Year:  2020        PMID: 33271061      PMCID: PMC7770071          DOI: 10.1016/j.cell.2020.11.005

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  20 in total

Review 1.  Alternative functions of CRISPR-Cas systems in the evolutionary arms race.

Authors:  Prarthana Mohanraju; Chinmoy Saha; Peter van Baarlen; Rogier Louwen; Raymond H J Staals; John van der Oost
Journal:  Nat Rev Microbiol       Date:  2022-01-06       Impact factor: 60.633

2.  Structural basis for target site selection in RNA-guided DNA transposition systems.

Authors:  Amy Wei-Lun Tsai; Eshan Mehrotra; Michael T Petassi; Shan-Chi Hsieh; Jung-Un Park; Ailong Ke; Joseph E Peters; Elizabeth H Kellogg
Journal:  Science       Date:  2021-07-15       Impact factor: 63.714

Review 3.  Genomic landscapes of bacterial transposons and their applications in strain improvement.

Authors:  Shengrui Wu; Pingfang Tian; Tianwei Tan
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-12       Impact factor: 5.560

Review 4.  Structural biology of CRISPR-Cas immunity and genome editing enzymes.

Authors:  Joy Y Wang; Patrick Pausch; Jennifer A Doudna
Journal:  Nat Rev Microbiol       Date:  2022-05-13       Impact factor: 78.297

5.  Structural basis for DNA targeting by the Tn7 transposon.

Authors:  Yao Shen; Josue Gomez-Blanco; Michael T Petassi; Joseph E Peters; Joaquin Ortega; Alba Guarné
Journal:  Nat Struct Mol Biol       Date:  2022-02-16       Impact factor: 18.361

6.  Dual modes of CRISPR-associated transposon homing.

Authors:  Makoto Saito; Alim Ladha; Jonathan Strecker; Guilhem Faure; Edwin Neumann; Han Altae-Tran; Rhiannon K Macrae; Feng Zhang
Journal:  Cell       Date:  2021-03-25       Impact factor: 41.582

7.  Unbiased profiling of CRISPR RNA-guided transposition products by long-read sequencing.

Authors:  Phuc Leo H Vo; Christopher Acree; Melissa L Smith; Samuel H Sternberg
Journal:  Mob DNA       Date:  2021-06-08

Review 8.  CRISPR-based genome editing through the lens of DNA repair.

Authors:  Tarun S Nambiar; Lou Baudrier; Pierre Billon; Alberto Ciccia
Journal:  Mol Cell       Date:  2022-01-20       Impact factor: 17.970

9.  Evolutionary and mechanistic diversity of Type I-F CRISPR-associated transposons.

Authors:  Sanne E Klompe; Nora Jaber; Leslie Y Beh; Jason T Mohabir; Aude Bernheim; Samuel H Sternberg
Journal:  Mol Cell       Date:  2022-01-19       Impact factor: 19.328

10.  Distribution and phasing of sequence motifs that facilitate CRISPR adaptation.

Authors:  Andrew Santiago-Frangos; Murat Buyukyoruk; Tanner Wiegand; Pushya Krishna; Blake Wiedenheft
Journal:  Curr Biol       Date:  2021-06-25       Impact factor: 10.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.